Showing results (161-170 of 175) with videos related to
Sort By:
Pageof 18
Jac-Antimicrobial Resistance|March 11, 2026
Randomized double-blind clinical trial evaluating the effectiveness and safety of secondary prophylaxis with oral vancomycin versus placebo in the prevention of recurrence of <i>clostridioides difficile</i> infection in patients receiving systemic antibiotic therapy (PREVAN trial)Rafael San-Juan, Julia Origüen, Mario Fernández-Ruiz, et al.British Journal of Haematology|September 19, 2023
Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemiaFabíola Attié de Castro, Parinaz Mehdipour, Ankur Chakravarthy, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2021
Eradication of Staphylococcus aureus Post-Sternotomy Mediastinitis Following the Implementation of Universal Preoperative Nasal Decontamination With Mupirocin: An Interrupted Time-Series AnalysisRafael San-Juan, Consuelo Alejandra Gotor-Pérez, Francisco López-Medrano, et al.Journal of Insect Science (Online)|June 6, 2023
Entomology beyond research and education: 2022 student debatesRamandeep Kaur Sandhi, Victoria Pickens, Elizabeth Bello, et al.Proceedings of the National Academy of Sciences of the United States of America|May 8, 2023
Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survivalJuliana Poças, Catarina Marques, Catarina Gomes, et al.European Journal of Cancer (Oxford, England : 1990)|March 5, 2025
Exploring the integration of patient-reported outcome measures in clinical practice: A cross-sectional survey of EORTC healthcare professionalsJens Lehmann, Tatiana Dragan, Elke Rammant, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2019
Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients-Results of a Spanish multicenter cohortFrancisco López-Medrano, José Tiago Silva, Mario Fernández-Ruiz, et al.Antimicrobial Agents and Chemotherapy|February 9, 2021
Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a Spanish multicenter cohortMaría Ruiz-Ruigómez, Mario Fernández-Ruiz, José Tiago Silva, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 1, 2021
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective studyFrancisco López-Medrano, María Asunción Pérez-Jacoiste Asín, Mario Fernández-Ruiz, et al.Open Forum Infectious Diseases|February 27, 2026
Clinical Presentation, Risk Factors and Outcome of Non-Tuberculous Mycobacteria Infection in Hematopoietic Stem-Cell Transplantation: A Multinational Case-Control StudyMario Fernández-Ruiz, Jose Tiago Silva, Peggy L Carver, et al.Pageof 18